Patents by Inventor Jaron Matthew Acker

Jaron Matthew Acker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230226291
    Abstract: A therapeutic gas source and cart and methods thereof for use with a therapeutic gas delivery system is disclosed. The therapeutic gas source may include a cylinder operable to contain a therapeutic gas that includes a body and a gas source valve body. In some examples, the gas source valve body has a valve and a coupling member.
    Type: Application
    Filed: February 14, 2023
    Publication date: July 20, 2023
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Jeffrey Martin Schmidt, Brian McCormack, Conor Briody
  • Patent number: 9259542
    Abstract: A differential pressure transducer determines pressure differentials between respiratory airflows and ambient airflows. Another determines pressure differentials between respiratory airflows and interface airflows. And another determines pressure differentials between i) respiratory airflows received from a subject and ii) interface airflows received from an area near a cannula. Corresponding respiratory monitoring methods also determine the same.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: February 16, 2016
    Assignee: General Electric Company
    Inventors: Jaron Matthew Acker, Robert Quin Yew Tham, Kristopher John Bilek, Andreas Tzanetakis
  • Patent number: 8752546
    Abstract: A method for mobilizing an occlusion from a breathing tube is presented. The method includes automatically mobilizing the occlusion from the breathing tube by regulating an inspiratory flow, an expiratory flow, or a combination thereof, where the breathing tube is configured to operationally couple a patient to a ventilation system, and where the ventilation system is configured to provide artificial respiration to the patient.
    Type: Grant
    Filed: April 23, 2008
    Date of Patent: June 17, 2014
    Assignee: General Electric Company
    Inventors: Jaron Matthew Acker, Andreas Tzanet Akis, Andrew Phillip Levi
  • Patent number: D1060405
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: February 4, 2025
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1061594
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: February 11, 2025
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1064285
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: February 25, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Brian McCormack, Michael McAtamney, Jaron Matthew Acker
  • Patent number: D1069817
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: April 8, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1086469
    Type: Grant
    Filed: October 24, 2024
    Date of Patent: July 29, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Brian McCormack, Michael McAtamney, Jaron Matthew Acker
  • Patent number: D1087129
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: August 5, 2025
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1092732
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: September 9, 2025
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1108635
    Type: Grant
    Filed: February 14, 2023
    Date of Patent: January 6, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Michael McAtamney, Jaron Matthew Acker, Curtis Irwin, Jake Martyn Goodwin
  • Patent number: D1120338
    Type: Grant
    Filed: June 17, 2025
    Date of Patent: March 24, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Brian McCormack, Michael McAtamney, Jaron Matthew Acker
  • Patent number: D1125541
    Type: Grant
    Filed: August 4, 2025
    Date of Patent: May 5, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1125542
    Type: Grant
    Filed: August 4, 2025
    Date of Patent: May 5, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1125543
    Type: Grant
    Filed: September 5, 2025
    Date of Patent: May 5, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1126242
    Type: Grant
    Filed: October 24, 2024
    Date of Patent: May 12, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1135921
    Type: Grant
    Filed: October 10, 2024
    Date of Patent: July 21, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Jaron Matthew Acker, Curtis Irwin, Kenneth Lee Soliva
  • Patent number: D1137678
    Type: Grant
    Filed: October 16, 2025
    Date of Patent: July 28, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Michael McAtamney, Jaron Matthew Acker, Curtis Irwin, Jake Martyn Goodwin
  • Patent number: D1146020
    Type: Grant
    Filed: August 4, 2025
    Date of Patent: September 1, 2026
    Assignee: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
    Inventors: Jaron Matthew Acker, Craig R. Tolmie, Curtis Irwin
  • Patent number: D1147367
    Type: Grant
    Filed: October 16, 2025
    Date of Patent: September 8, 2026
    Assignee: Mallinckrodt Pharmaceuticals Ireland Limited
    Inventors: Michael McAtamney, Jaron Matthew Acker, Curtis Irwin, Jake Martyn Goodwin